Details
Stereochemistry | RACEMIC |
Molecular Formula | C15H25NO2.ClH |
Molecular Weight | 287.825 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC1=C(C)C(OCC(O)CNC(C)(C)C)=CC=C1
InChI
InChIKey=ZNEAHTMGASMSKT-UHFFFAOYSA-N
InChI=1S/C15H25NO2.ClH/c1-11-7-6-8-14(12(11)2)18-10-13(17)9-16-15(3,4)5;/h6-8,13,16-17H,9-10H2,1-5H3;1H
Molecular Formula | C15H25NO2 |
Molecular Weight | 251.3645 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs. | 1977 Jan |
|
Analysis of beta-adrenoceptors mediating renin release produced by isoproterenol in conscious dogs. | 1980 May |
|
Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs. | 1981 Feb |
|
[Antihypertensive action of adrenergic beta-receptor blockers and its effect on the entire sympathetic outflow in spontaneously hypertensive rats]. | 1982 Dec |
|
Effects of beta-adrenoceptor blocking agents of N-tertiary butyl derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles. | 1983 Sep |
|
Stereoselectivity in the metabolism of the beta-adrenergic blocking agent, (+/-)-1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol hydrochloride (xibenolol hydrochloride, D-32), in man. | 1985 Feb |
|
[Stereoselective glucuronidation of beta-blocking agents, 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32) and propranolol, in animals, in vivo and in vitro]. | 1986 May |
Patents
Sample Use Guides
dogs:
50 mg/kg, p.o.
1 mg/kg per min for 5 min i.v.
rats:
2 X 15 or 2 X 50 mg/kg/day p.o.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6138715
The effects of xibenolol (D-32) (17.3-100 uM) on action potentials were investigated in isolated guinea-pig papillary muscles.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:21:43 GMT 2023
by
admin
on
Sat Dec 16 08:21:43 GMT 2023
|
Record UNII |
86P3XQL90N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Brand Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m1269
Created by
admin on Sat Dec 16 08:21:43 GMT 2023 , Edited by admin on Sat Dec 16 08:21:43 GMT 2023
|
PRIMARY | Merck Index | ||
|
298820
Created by
admin on Sat Dec 16 08:21:43 GMT 2023 , Edited by admin on Sat Dec 16 08:21:43 GMT 2023
|
PRIMARY | |||
|
86P3XQL90N
Created by
admin on Sat Dec 16 08:21:43 GMT 2023 , Edited by admin on Sat Dec 16 08:21:43 GMT 2023
|
PRIMARY | |||
|
DTXSID7021445
Created by
admin on Sat Dec 16 08:21:43 GMT 2023 , Edited by admin on Sat Dec 16 08:21:43 GMT 2023
|
PRIMARY | |||
|
146255
Created by
admin on Sat Dec 16 08:21:43 GMT 2023 , Edited by admin on Sat Dec 16 08:21:43 GMT 2023
|
PRIMARY | |||
|
59708-57-5
Created by
admin on Sat Dec 16 08:21:43 GMT 2023 , Edited by admin on Sat Dec 16 08:21:43 GMT 2023
|
SUPERSEDED | |||
|
15263-30-6
Created by
admin on Sat Dec 16 08:21:43 GMT 2023 , Edited by admin on Sat Dec 16 08:21:43 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|